Added to YB: 2026-08-07
Pitch date: 2026-08-04
STVN [neutral]
Stevanato Group S.p.A.
+2.68%
current return
Author Info
Best Anchor Stocks shares deep research on companies with long-term potential aThe Bear Cavend lower-than-average volatility. Sign up for the newsletter.
Company Info
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.
Market Cap
$4.8B
Pitch Price
$19.76
Price Target
N/A
Dividend
0.31%
EV/EBITDA
16.50
P/E
35.53
EV/Sales
4.18
Sector
Life Sciences Tools and Services
Category
growth
The tip of the iceberg. - $STVN
STVN (holding update): Q2 rev +8% organic, BDS +10% cc (HVS +18%), adj EBITDA +21%, adj op margin +250bps. Balda divestiture cut reported guide €5M but organic guide raised marginally; adj EBITDA guide up. Poor communication is unforced error. GLP-1 (only 10% penetrated of 1.5B TAM), biosimilars, Alina integrated pen, and larger biologics pipeline drive durable double-digit growth for 5-10yrs. Engineering (12% rev) stabilizing. Holding shares despite +20% pop being unwarranted.
Read full article (7 min)